CollPlant Biotechnologies Ltd. (CLGN) Revenue History
Annual and quarterly revenue from 2012 to present
CLGN Revenue Over Time (2012–2025)
CLGN Revenue Growth History
6 of 9 years with positive growth- FY2012 revenue growth
- N/A
- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- +532.2%
- FY2018 revenue growth
- +897.8%
- FY2019 revenue growth
- -51.6%
- FY2020 revenue growth
- +164.8%
- FY2021 revenue growth
- +154.9%
- FY2022 revenue growth
- -98.1%
- FY2023 revenue growth
- +3565.2%
- FY2024 revenue growth
- -95.3%
- FY2025 revenue growth
- +360.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $73K | -96.4% |
| Q4 2025 | $60K | -63.4% |
| Q3 2025 | $77K | +1825.0% |
| Q2 2025 | $179K | -28.1% |
| Q1 2025 | $2.1M | +1996.9% |
| Q4 2024 | $164K | -45.2% |
| Q3 2024 | $4K | -90.7% |
| Q2 2024 | $249K | -97.6% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown
CLGN's revenue distribution by segment and geography
By Geography
CLGN Revenue Analysis (2012–2025)
Current Revenue & Growth
As of June 23, 2026, CollPlant Biotechnologies Ltd. (CLGN) generated trailing twelve-month (TTM) revenue of $389,000, reflecting significant decline in growth of -96.4% year-over-year. The most recent quarter (Q1 2026) recorded $73,000 in revenue, up 21.7% sequentially.
Historical Growth Trajectory
CLGN's 5-year compound annual growth rate (CAGR) stands at -17.3%, indicating revenue contraction over this period. The 3-year CAGR of +99.4% exceeds the 5-year average, indicating an acceleration in the most recent period. CollPlant Biotechnologies Ltd.'s highest annual revenue of $15.6 million was recorded in 2021.
Peer Comparison
Compared to Healthcare sector peers — including RGEN (+17.4% YoY), HALO (+39.1% YoY), and AGIO (+78.3% YoY) — CLGN has underperformed the peer group in revenue growth. Compare CLGN vs RGEN →
CLGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLGNCurrent | $389,000 | -96.4% | -17.3% | -484.3% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 HALO | $1.4B | +39.1% | +39.2% | 58.4% | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
CLGN Historical Revenue Data (2012–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.4M | +360.4% | $624K | 26.3% | $-11,483,000 | -484.3% |
| 2024 | $515K | -95.3% | $-2,148,000 | -417.1% | $-17,251,000 | -3349.7% |
| 2023 | $11.0M | +3565.2% | $7.9M | 71.8% | $-7,512,000 | -68.5% |
| 2022 | $299K | -98.1% | $-1,177,000 | -393.6% | $-17,097,000 | -5718.1% |
| 2021 | $15.6M | +154.9% | $13.6M | 87.2% | $65K | 0.4% |
| 2020 | $6.1M | +164.8% | $2.7M | 43.7% | $-5,599,000 | -91.2% |
| 2019 | $2.3M | -51.6% | $439K | 18.9% | $-7,631,000 | -329.2% |
| 2018 | $4.8M | +897.8% | $3.1M | 65.0% | $-4,065,636 | -84.9% |
| 2017 | $480K | +532.2% | $158K | 32.8% | $-5,971,055 | -1244.2% |
| 2016 | $76K | - | $-149,006 | -196.3% | $-7,160,869 | -9433.2% |
| 2015 | $0 | - | $-202,819 | - | $-4,819,580 | - |
| 2014 | $0 | - | $-224,198 | - | $-3,502,888 | - |
| 2013 | $0 | - | $-263,470 | - | $-4,646,375 | - |
| 2012 | $0 | - | $-316,612 | - | $-4,640,331 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CLGN — Frequently Asked Questions
Quick answers to the most common questions about buying CLGN stock.
Is CLGN's revenue growth accelerating or slowing?
CLGN revenue is declining -96.4% year-over-year. TTM revenue fell to $389000.00, contrasting with the 5-year CAGR of -17.3%. The reversal reflects either macro headwinds or company-specific challenges.
What is CLGN's revenue history from 2012 to 2026?
CollPlant Biotechnologies Ltd. (CLGN) revenue history spans 2012 to 2026. TTM revenue as of 2026 is $389000.00, growing at -96.4% YoY. The 5-year CAGR is -17.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CLGN's long-term revenue growth rate (CAGR)?
CollPlant Biotechnologies Ltd.'s 5-year revenue CAGR of -17.3% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -96.4% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CLGN.
Why does CLGN's quarterly revenue fluctuate?
CLGN quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. CollPlant Biotechnologies Ltd.'s revenue data from 2012 to 2026 shows full historical quarterly detail on this page.
How is CLGN's revenue distributed by segment?
CLGN reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CLGN's revenue compare to industry peers?
CollPlant Biotechnologies Ltd. (CLGN) with TTM revenue of $389000.00 and -96.4% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.